American Society of Hematology

SHERPA: Blue

People

  1. Abdel-Wahab
    Abdel-Wahab
  2. Brody
    Brody
  3. Diamond
    Diamond
  4. Dogan
    Dogan
  5. Durham
    Durham
  6. Rampal
    Rampal

Groups

  1. Adult Leukemia (1)
  2. Center for Hematologic Malignancies (1)
  3. Department of Medicine (1)
  4. Early Drug Development Service (1)
  5. Executive Committee, Center for Hematologic Malignancies (1)
  6. GSK Faculty (1)
  7. Hematologic Malignancies, Division of (1)
  8. Human Oncology and Pathogenesis Program (1)
  9. Interventional Radiology Service (1)
  10. Molecular Imaging and Therapy Service (1)
Search Within
  1. "Human Oncology and Pathogenesis Program"
  2. "Gary Ulaner"
  3. "Lynn Brody"
  4. "Omar Abdel-Wahab"
  5. "Blood"
Formats
  1. Meeting Abstract (1)
Groups
  1. Adult Leukemia (1)
  2. Center for Hematologic Malignancies (1)
  3. Department of Medicine (1)
  4. Early Drug Development Service (1)
  5. Executive Committee, Center for Hematologic Malignancies (1)
  6. GSK Faculty (1)

More Groups

People
  1. Ahmet Dogan (1)
  2. Benjamin Durham (1)
  3. David Hyman (1)
  4. Eli Diamond (1)
  5. Gary Ulaner (1)
  6. Lynn Brody (1)

More People

Years
  1. 2017 (1)
Publications
  1. Blood (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 trial of single-agent cobimetinib for adults with BRAF V600-mutant and wild-type histiocytic disorders
    Meeting Abstract

    Diamond, E. L.; Durham, B. H.; Dogan, A.; Hyman, D. M.; Rampal, R. K.; Ulaner, G.; Brody, L.; Abdel-Wahab, O.
    Blood (2017)

    Fulltext@MSK | Save